Daniah Alshowaeir1, Con Yannikas2, Raymond Garrick3, Anneke Van Der Walt4, Stuart L Graham5, Clare Fraser6, Alexander Klistorner7. 1. Department of Ophthalmology, University of Sydney, Sydney, Australia; Department of Ophthalmology, King Saud University, Riyadh, Saudi Arabia. Electronic address: d_alshowair@hotmail.com. 2. Concord Hospital, Sydney, Australia; Department of Neurology, Royal North Shore Hospital, Sydney, Australia. 3. Department of Neurology, St Vincent Hospital, Sydney, Australia. 4. Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia. 5. Department of Ophthalmology, Macquarie University, Sydney, Australia. 6. Department of Ophthalmology, University of Sydney, Sydney, Australia. 7. Department of Ophthalmology, University of Sydney, Sydney, Australia; Australian School of Advanced Medicine, Macquarie University, Sydney, Australia.
Abstract
OBJECTIVE: To evaluate multifocal visual evoked potentials (mfVEP) changes in optic neuritis (ON) and fellow eyes during first year after the attack. METHODS: Eighty-seven patients and twenty-five controls were examined. Patients were classified as multiple sclerosis (MS) group, high risk (HR) or low risk (LR) groups for conversion to MS. mfVEP recordings and retinal nerve fiber layer (RNFL) thickness were analyzed. RESULTS: Recovery of amplitude and shortening of latency was fastest within the first 3months. The largest amplitude reduction and longest latency delay of the ON eye were recorded in the MS group. This was accompanied by deterioration of both parameters in fellow eyes (p<0.03). mfVEP remained stable in fellow eyes of the LR group. Inter-eye asymmetry showed similar amount of amplitude reduction and latency delay in all three groups. RNFL thickness strongly correlated with mfVEP amplitude as early as 3 months after ON (R(2)=0.6, p=0.001). CONCLUSION: mfVEP amplitude is an early predictor of post-ON axonal loss. The apparent more severe involvement of ON eyes in the MS subgroup may be due to subclinical inflammation along the visual pathway. SIGNIFICANCE: Severity of amplitude reduction and latency delay after episode of ON is not MS-related. Retro-chiasmal demyelination is a possible factor contributing to amplitude and latency differences between MS and non-MS patients.
OBJECTIVE: To evaluate multifocal visual evoked potentials (mfVEP) changes in optic neuritis (ON) and fellow eyes during first year after the attack. METHODS: Eighty-seven patients and twenty-five controls were examined. Patients were classified as multiple sclerosis (MS) group, high risk (HR) or low risk (LR) groups for conversion to MS. mfVEP recordings and retinal nerve fiber layer (RNFL) thickness were analyzed. RESULTS: Recovery of amplitude and shortening of latency was fastest within the first 3months. The largest amplitude reduction and longest latency delay of the ON eye were recorded in the MS group. This was accompanied by deterioration of both parameters in fellow eyes (p<0.03). mfVEP remained stable in fellow eyes of the LR group. Inter-eye asymmetry showed similar amount of amplitude reduction and latency delay in all three groups. RNFL thickness strongly correlated with mfVEP amplitude as early as 3 months after ON (R(2)=0.6, p=0.001). CONCLUSION: mfVEP amplitude is an early predictor of post-ON axonal loss. The apparent more severe involvement of ON eyes in the MS subgroup may be due to subclinical inflammation along the visual pathway. SIGNIFICANCE: Severity of amplitude reduction and latency delay after episode of ON is not MS-related. Retro-chiasmal demyelination is a possible factor contributing to amplitude and latency differences between MS and non-MS patients.
Authors: Luis de Santiago; E M Sánchez Morla; Miguel Ortiz; Elena López; Carlos Amo Usanos; M C Alonso-Rodríguez; R Barea; Carlo Cavaliere-Ballesta; Alfredo Fernández; Luciano Boquete Journal: PLoS One Date: 2019-04-04 Impact factor: 3.240
Authors: Minh N L Nguyen; Chao Zhu; Scott C Kolbe; Helmut Butzkueven; Owen B White; Joanne Fielding; Trevor J Kilpatrick; Gary F Egan; Alexander Klistorner; Anneke van der Walt Journal: Front Neurol Date: 2022-09-08 Impact factor: 4.086